CompletedPhase 3NCT00594737

Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tiffany Chow, MD
Principal Investigator
Tiffany W Chow, MD, M.D
Rotman Research Institute at Baycrest, University of Toronto
Intervention
memantine hydrochloride(drug)
Enrollment
17 enrolled
Eligibility
40-80 years · All sexes
Timeline
20072012

Study locations (1)

Collaborators

H. Lundbeck A/S

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00594737 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials